U.S. Markets closed

Cerus Corporation (CERS)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
2.60-0.01 (-0.38%)
At close: 4:00PM EDT
People also watch
CRISCGENBCRXARRYCYTK
Full screen
Previous Close2.61
Open2.60
Bid2.44 x 200
Ask3.42 x 400
Day's Range2.54 - 2.64
52 Week Range1.93 - 6.59
Volume649,182
Avg. Volume834,496
Market Cap283.76M
Beta1.21
PE Ratio (TTM)-4.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Cerus Corp. : September 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cerus Corp. Here are 5 ETFs with the largest exposure to CERS-US. Comparing the performance and risk of Cerus Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cerus Corp. :CERS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
    Capital Cube3 days ago

    Cerus Corp. :CERS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Cerus Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cerus Corp. – Haemonetics Corporation, Cytori Therapeutics, Inc., Teligent, Inc., Vical Incorporated, Cesca Therapeutics Inc. and BioTime, Inc. (HAE-US, CYTX-US, TLGT-US, VICL-US, KOOL-US and BTX-US) that have also reported ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CERS earnings conference call or presentation 3-Aug-17 8:15pm GMT

    Q2 2017 Cerus Corp Earnings Call